Ligand validation:5L6C

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5L6C_MES_Y_302	16%	18%	0.261	0.828	2.29	1.28	1	2	0	0	100%	0.5
5L6B_MES_V_302	39%	15%	0.235	0.941	2.17	1.58	1	2	1	0	100%	1
5L67_MES_K_303	35%	15%	0.212	0.903	2.34	1.47	1	3	2	0	100%	0.5
5L68_MES_H_302	34%	13%	0.245	0.931	2.05	1.87	1	3	2	0	100%	0.9
5L5D_MES_H_302	34%	18%	0.253	0.936	2.22	1.32	1	3	0	0	100%	1
5L5J_MES_H_302	33%	10%	0.253	0.935	2.38	1.99	1	4	4	0	100%	0.8
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	23%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	21%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1
5NJ9_MES_A_502	99%	62%	0.049	0.988	0.71	0.74	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.